Research Update MAF D18CA-045 Final: Understanding the Relationship between Intestinal Bacteria and Inflammatory Bowel Disease (IBD)

RESULTS: Researchers map microbiome in dogs with canine inflammatory disease
Morris Animal Foundation-funded researchers at the University of Melbourne, Australia, studied if specific gut bacteria can drive or exacerbate intestinal inflammation in dogs with inflammatory bowel disease or chronic enteropathy. Their findings could inform continuing studies on how the gut microbiome may be manipulated for novel treatments as well as inform the development of new diagnostics. Continue reading “Research Update MAF D18CA-045 Final: Understanding the Relationship between Intestinal Bacteria and Inflammatory Bowel Disease (IBD)”

Research Update MAF D16CA-056 Final: Measuring Chemotherapy Drug Resistance in Dogs with T-cell Lymphoma

RESULTS: New Technology Helps Detect Small Amounts of Drug-Resistant Cancer Cells in Dogs with T-cell Lymphoma.

Morris Animal Foundation-funded researchers from North Carolina State University used state-of-the-art DNA technology to help detect small amounts of drug-resistant cancer cells that persist after treatment in dogs with T-cell lymphoma (minimal residual disease, MRD). Accurately monitoring MRD could provide a fuller picture of the effectiveness of different drugs and improve treatment success, quality of life and survival for these patients. Continue reading “Research Update MAF D16CA-056 Final: Measuring Chemotherapy Drug Resistance in Dogs with T-cell Lymphoma”